Man develops severe liver damage after taking epsom salts
A 38-year-old man developed serious liver damage after taking epsom salts to treat gallstones, reveal doctors in the journal BMJ Case Reports.
Oct 2, 2017
0
0
A 38-year-old man developed serious liver damage after taking epsom salts to treat gallstones, reveal doctors in the journal BMJ Case Reports.
Oct 2, 2017
0
0
According to current estimates, 20 to 25 million Americans have or will develop gallstones, representing almost 15% of adults. Although only a small percentage of individuals with gallstones develop symptoms, more than 700,000 ...
Mar 13, 2017
0
2
(HealthDay)—Dietary factors are associated with pancreatitis, with saturated fat and cholesterol positively linked to gallstone-related acute pancreatitis (AP), according to a study published in the February issue of Clinical ...
Jan 30, 2017
0
0
A history of gallstone disease may increase your risk of coronary heart disease, according to new research in the American Heart Association's journal Arteriosclerosis, Thrombosis and Vascular Biology.
Aug 18, 2016
0
1
A recent study conducted by Mayo Clinic researchers recommends laparoscopic cholecystectomies (surgical removal of the gallbladder) for pediatric patients suffering from gallstones and other gallbladder diseases. This study ...
Aug 7, 2014
0
0
New research reveals a causal association between elevated body mass index (BMI) and increased risk of gallstone disease. Results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, ...
Jul 11, 2013
0
0
Oral estrogen therapy for menopausal women is associated with an increased risk of gallbladder surgery, according to a large-scale study of more than 70 000 women in France published in CMAJ (Canadian Medical Association ...
Mar 18, 2013
0
0
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
Feb 25, 2013
1
0
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Dec 17, 2012
0
0
Children who are overweight or obese face an increased risk for gallstones, according to a Kaiser Permanente study published in the Journal of Pediatric Gastroenterology & Nutrition.
Aug 24, 2012
0
0